| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.4M | +33.1% |
| Cost of Revenue | $11.9M | +73.2% |
| R&D Expense | $2.4M | -32.7% |
| SG&A Expense | $15.1M | +245.1% |
| Operating Income | -$18.4M | -1315.3% |
| Interest Expense | $10K | — |
| Net Income | -$28.3M | -4646.2% |
| EPS (Basic) | -$1.75 | -3400.0% |
| EPS (Diluted) | -$1.75 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $5.0M | — |
| Accounts Receivable | $1.6M | +104.3% |
| Inventory | $6.7M | — |
| Current Assets | $37.0M | +6135.6% |
| Total Assets | $52.6M | -69.9% |
| Current Liabilities | $3.9M | +1062.2% |
| Long-term Debt | $15.9M | +8.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.3M | -3484.8% |
| Capital Expenditures | $14.2M | +1444.4% |
| Investing Cash Flow | -$19.2M | +89.0% |
| Financing Cash Flow | $53.3M | -69.7% |
| Free Cash Flow | -$51.5M | -2525.6% |
| -11.5% |
| Total Liabilities |
| $52.6M |
| +532.9% |
| Stockholders' Equity | $28K | +100.4% |